Compounding Pharmacy Merchant Services — We Don’t Consider You High Risk
Compounding pharmacy merchant services should not be this hard to find. If you run a licensed compounding pharmacy or FDA-registered 503B outsourcing facility, processors have probably told you that you are high risk. They may have declined your application, charged inflated fees, or shut your account down without warning. At Revolution Payments, we do not start from that assumption — and that changes everything about how we work with your business.
Why Processors Label Compounding Pharmacies High Risk
Most payment processors see the word pharmacy and apply a blanket high-risk classification. They do not review your license, your compliance history, or how your business actually operates. That single assumption drives up your costs. It also creates account instability that has nothing to do with your actual risk profile.
The reality is straightforward. Licensed compounding pharmacies operate under strict state board oversight. Furthermore, FDA-registered 503B outsourcing facilities follow the same cGMP standards as pharmaceutical manufacturers. Regulators inspect these businesses regularly and hold them to strict federal and state requirements. These facilities serve hospitals, clinics, and healthcare institutions — not individual consumers buying medication online. Every one of these businesses deserves a stable, fairly priced merchant account. The problem sits with the processor assumption — not your business.
Compounding Pharmacy Merchant Accounts for 503A and 503B Facilities
Finding a stable compounding pharmacy merchant account should not be this difficult. When we set up your account correctly from the start, several things change immediately. First, we place you with an acquiring bank that understands the pharmaceutical industry. Not every bank supports compounding pharmacies. Moreover, some banks that approve you today may exit the space without warning. Working with the right bank from day one means your account stays stable long-term — not just through the initial approval. Additionally, your processing costs reflect your actual risk. That means no inflated reserves, no excessive fees, and no surprises on your monthly statement.
We understand the underwriting and interchange challenges compounding pharmacies face because we work directly with B2B and regulated healthcare environments. That experience means we know how to structure your account correctly the first time.
503B Outsourcing Facilities and Payment Processing
503B outsourcing facilities face an additional challenge. Many processors do not understand how to properly underwrite 503B merchant services accounts. The 503B designation arrived in 2013 under the Drug Quality and Security Act. Consequently, processors often misclassify these businesses or decline them entirely.
A 503B facility is not a retail pharmacy. Instead, it sells bulk sterile medications to hospitals, surgery centers, and clinics. Its customers pay with commercial purchasing cards and corporate accounts — not consumer credit cards. Therefore, the risk profile differs fundamentally from a retail pharmacy. We treat it that way from the start.
When we classify 503B facilities correctly, two things happen. First, we underwrite the account against the right risk criteria. Second, the B2B nature of the transactions opens the door to enhanced data interchange rates. That means lower processing costs on every commercial card transaction. A 503B merchant account with the right structure performs very differently from one built on consumer pharmacy assumptions.
The Interchange Problem Most Compounding Pharmacies Miss
Whether you run a 503A compounding pharmacy or a 503B outsourcing facility, you are likely leaving money on the table. This happens when a significant portion of your volume comes from commercial accounts.
Commercial purchasing cards, corporate cards, and virtual cards qualify for lower interchange rates. However, that only happens when transactions include the right enhanced data. Most processors never configure this. Therefore, transactions qualify at higher consumer card rates instead of the lower B2B rates they should hit. Furthermore, interchange makes up the majority of total processing cost — not the processor margin. Fixing this is where the real savings come from. A statement review finds this problem immediately. In many cases the savings turn out to be significant.
Who This Is For
Revolution Payments works with licensed 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, bulk pharmaceutical ingredient suppliers, and pharmaceutical manufacturers selling B2B. If your business operates legally and processors keep turning you away, you are exactly who we work with. In fact, if a processor has told you that you are high risk, that is exactly the type of conversation we specialize in — compounding pharmacies and 503B facilities that other processors turned down are our best clients.
Get a Free Compounding Pharmacy Statement Review
Send us a recent Visa and Mastercard statement and we will show you exactly what you are paying. We will also confirm whether your compounding pharmacy merchant account hits the right interchange levels and whether money sits on the table. In fact, most merchants find savings they did not know existed.
No obligation — just a straight answer on whether your account is set up correctly and whether your transactions qualify the way they should. Beyond the statement review, we are happy to answer any questions about how we work with compounding pharmacies and 503B facilities. Call 888-790-3450 or email info@ revolution-payments.com to get started. Revolution Payments provides compounding pharmacy merchant services for licensed 503A and 503B facilities nationwide.